TreeWAS – Variant ID: rs2227631

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I83.1 Varicose veins of lower extremities with inflammation	0.059	0.941	0.000
I83 Varicose veins of lower extremities	0.044	0.956	0.000
I84.9 Unspecified haemorrhoids without complication	0.041	0.959	0.000
I87.8 Other specified disorders of veins	0.038	0.962	0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.037	0.963	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.036	0.964	0.000
I87 Other disorders of veins	0.036	0.964	0.000
I82 Other venous embolism and thrombosis	0.036	0.964	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.036	0.964	0.000
K62.1 Rectal polyp	0.035	0.965	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.031	0.969	0.000
I82.8 Embolism and thrombosis of other specified veins	0.031	0.969	0.000
I82.2 Embolism and thrombosis of vena cava	0.031	0.969	0.000
I84 Haemorrhoids	0.030	0.970	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.030	0.970	0.000
I84.4 External haemorrhoids with other complications	0.030	0.970	0.000
I87.9 Disorder of vein, unspecified	0.029	0.971	0.000
I81 Portal vein thrombosis	0.029	0.971	0.000
Z83.3 Family history of diabetes mellitus	0.028	0.972	0.000
I89.1 Lymphangitis	0.028	0.972	0.000
I82.3 Embolism and thrombosis of renal vein	0.027	0.973	0.000
I87.0 Postphlebitic syndrome	0.026	0.974	0.000
I82.1 Thrombophlebitis migrans	0.026	0.974	0.000
I82.0 Budd-Chiari syndrome	0.026	0.974	0.000
I88 Nonspecific lymphadenitis	0.024	0.975	0.000
I89.0 Lymphoedema, not elsewhere classified	0.023	0.977	0.000
I84.5 External haemorrhoids without complication	0.023	0.977	0.000
I87.1 Compression of vein	0.022	0.978	0.000
I84.0 Internal thrombosed haemorrhoids	0.022	0.978	0.000
I86 Varicose veins of other sites	0.020	0.980	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.019	0.981	0.000
I84.3 External thrombosed haemorrhoids	0.019	0.981	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.981	0.019
I87.2 Venous insufficiency (chronic) (peripheral)	0.019	0.981	0.000
I88.9 Nonspecific lymphadenitis, unspecified	0.018	0.982	0.000
I88.1 Chronic lymphadenitis, except mesenteric	0.018	0.982	0.000
I88.0 Nonspecific mesenteric lymphadenitis	0.017	0.983	0.000
I88.8 Other nonspecific lymphadenitis	0.016	0.984	0.000
M13.96 Arthritis, unspecified (Lower leg)	0.000	0.985	0.015
O75.8 Other specified complications of labour and delivery	0.015	0.985	0.000
I86.3 Vulval varices	0.015	0.985	0.000
I86.1 Scrotal varices	0.015	0.985	0.000
I86.0 Sublingual varices	0.015	0.985	0.000
I85 Oesophageal varices	0.015	0.985	0.000
H36.0 Diabetic retinopathy	0.000	0.986	0.014
I86.8 Varicose veins of other specified sites	0.013	0.987	0.000
I86.2 Pelvic varices	0.013	0.987	0.000
N05.9 Unspecified	0.013	0.987	0.000
O75 Other complications of labour and delivery, not elsewhere classified	0.013	0.987	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.012	0.987	0.000
I86.4 Gastric varices	0.012	0.988	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.000	0.988	0.012
O75.7 Vaginal delivery following previous Caesarean section	0.011	0.989	0.000
Z83 Family history of other specific disorders	0.011	0.989	0.000
I84.7 Unspecified thrombosed haemorrhoids	0.011	0.989	0.000
O75.0 Maternal distress during labour and delivery	0.010	0.990	0.000
Z83.5 Family history of eye and ear disorders	0.010	0.990	0.000
O75.3 Other infection during labour	0.010	0.990	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.010	0.990	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.010	0.990	0.000
I85.0 Oesophageal varices with bleeding	0.009	0.991	0.000
O75.9 Complication of labour and delivery, unspecified	0.009	0.991	0.000
O75.5 Delayed delivery after artificial rupture of membranes	0.009	0.991	0.000
O75.4 Other complications of obstetric surgery and procedures	0.009	0.991	0.000
O75.1 Shock during or following labour and delivery	0.009	0.991	0.000
Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.009	0.991	0.000
O30.0 Twin pregnancy	0.009	0.991	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.991	0.009
D25.0 Submucous leiomyoma of uterus	0.000	0.991	0.009
Z83.0 Family history of human immunodeficiency virus [HIV]	0.008	0.992	0.000
Z83.7 Family history of diseases of the digestive system	0.008	0.992	0.000
D35.1 Parathyroid gland	0.008	0.992	0.000
Z83.6 Family history of diseases of the respiratory system	0.007	0.993	0.000
I84.1 Internal haemorrhoids with other complications	0.007	0.993	0.000
Z83.1 Family history of other infectious and parasitic diseases	0.007	0.993	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.993	0.006
U83 Resistance to other antibiotics	0.000	0.993	0.006
U82 Resistance to betalactam antibiotics	0.000	0.993	0.006
U85 Resistance to antineoplastic drugs	0.000	0.993	0.006
N05 Unspecified nephritic syndrome	0.006	0.994	0.000
H36 Retinal disorders in diseases classified elsewhere	0.000	0.994	0.006
U89 Agent resistant to other and unspecified antibiotics	0.000	0.994	0.005
S62.30 Fracture of other metacarpal bone (closed)	0.006	0.994	0.000
C16.0 Cardia	0.000	0.995	0.005
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.995	0.005
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.995	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.995	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.005	0.995	0.000
Z83.4 Family history of other endocrine, nutritional and metabolic diseases	0.005	0.995	0.000
N05.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
I84.2 Internal haemorrhoids without complication	0.005	0.995	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.995	0.005
U82.8 Resistance to other betalactam antibiotics	0.000	0.995	0.005
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.995	0.005
U82.1 Resistance to methicillin	0.000	0.995	0.005
U82.0 Resistance to penicillin	0.000	0.995	0.005
U83.9 Resistance to unspecified antibiotic	0.000	0.995	0.005
U83.8 Resistance to other single specified antibiotic	0.000	0.995	0.005
U83.7 Resistance to multiple antibiotics	0.000	0.995	0.005
U83.2 Resistance to quinolones	0.000	0.995	0.005
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.995	0.005
U83.0 Resistance to vancomycin	0.000	0.995	0.005
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.995	0.005
U84.8 Resistance to other specified antimicrobial drug	0.000	0.995	0.005
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.995	0.005
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.995	0.005
U84.2 Resistance to antiviral drug(s)	0.000	0.995	0.005
U84.1 Resistance to antifungal drug(s)	0.000	0.995	0.005
U84.0 Resistance to antiparasitic drug(s)	0.000	0.995	0.005
N05.6 Dense deposit disease	0.005	0.995	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.995	0.000
N05.0 Minor glomerular abnormality	0.005	0.995	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.000	0.995	0.005
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.000	0.995	0.005
R52.1 Chronic intractable pain	0.005	0.995	0.000
L27 Dermatitis due to substances taken internally	0.000	0.995	0.005
I84.8 Unspecified haemorrhoids with other complications	0.005	0.995	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.995	0.005
N05.1 Focal and segmental glomerular lesions	0.004	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
O30 Multiple gestation	0.004	0.995	0.000
I84.6 Residual haemorrhoidal skin tags	0.004	0.996	0.000
C16.9 Stomach, unspecified	0.000	0.996	0.004
C77.3 Axillary and upper limb lymph nodes	0.004	0.996	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.000	0.996	0.004
C16 Malignant neoplasm of stomach	0.000	0.996	0.004
U89.9 Agent resistant to unspecified antibiotic	0.000	0.996	0.004
T42.4 Benzodiazepines	0.000	0.996	0.004
M10.99 Gout, unspecified (Site unspecified)	0.004	0.996	0.000
N64.4 Mastodynia	0.000	0.996	0.004
N90.6 Hypertrophy of vulva	0.004	0.996	0.000
O30.1 Triplet pregnancy	0.004	0.996	0.000
H52.0 Hypermetropia	0.004	0.996	0.000
C16.2 Body of stomach	0.000	0.996	0.004
L27.9 Dermatitis due to unspecified substance taken internally	0.000	0.996	0.004
L27.8 Dermatitis due to other substances taken internally	0.000	0.996	0.004
N64.5 Other signs and symptoms in breast	0.000	0.996	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.004
N05.8 Other	0.003	0.996	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.003
T42.3 Barbiturates	0.000	0.996	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.003
O30.9 Multiple gestation, unspecified	0.003	0.996	0.000
O30.8 Other multiple gestation	0.003	0.996	0.000
O30.2 Quadruplet pregnancy	0.003	0.996	0.000
C16.4 Pylorus	0.000	0.997	0.003
C16.6 Greater curvature of stomach, unspecified	0.000	0.997	0.003
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.003	0.997	0.000
W02.9 Unspecified place	0.003	0.997	0.000
C16.1 Fundus of stomach	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
U89.8 Agent resistant to other single specified antibiotic	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.003	0.997	0.000
C16.8 Overlapping lesion of stomach	0.000	0.997	0.003
Chapter XXII Codes for special purposes	0.000	0.997	0.003
N90.3 Dysplasia of vulva, unspecified	0.003	0.997	0.000
L27.2 Dermatitis due to ingested food	0.000	0.997	0.003
C16.3 Pyloric antrum	0.000	0.997	0.003
Z37.2 Twins, both liveborn	0.003	0.997	0.000
N64 Other disorders of breast	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
C16.5 Lesser curvature of stomach, unspecified	0.000	0.997	0.003
H52.3 Anisometropia and aniseikonia	0.003	0.997	0.000
H04.8 Other disorders of lachrymal system	0.000	0.997	0.003
E10.3 With ophthalmic complications	0.000	0.997	0.003
N90 Other noninflammatory disorders of vulva and perineum	0.003	0.997	0.000
N64.9 Disorder of breast, unspecified	0.000	0.997	0.003
H52 Disorders of refraction and accommodation	0.003	0.997	0.000
O72.0 Third-stage haemorrhage	0.003	0.997	0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.003	0.997	0.000
I80 Phlebitis and thrombophlebitis	0.003	0.997	0.000
N04.9 Unspecified	0.003	0.997	0.000
E06.3 Autoimmune thyroiditis	0.003	0.997	0.000
M71.2 Synovial cyst of popliteal space [Baker]	0.000	0.997	0.003
M10.96 Gout, unspecified (Lower leg)	0.003	0.997	0.000
N90.5 Atrophy of vulva	0.003	0.997	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.997	0.003
N90.7 Vulvar cyst	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.000	0.997	0.003
Z72.0 Tobacco use	0.003	0.997	0.000
I85.9 Oesophageal varices without bleeding	0.002	0.998	0.000
H52.2 Astigmatism	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
N90.1 Moderate vulvar dysplasia	0.002	0.998	0.000
N64.3 Galactorrhoea not associated with childbirth	0.000	0.998	0.002
N64.2 Atrophy of breast	0.000	0.998	0.002
N64.0 Fissure and fistula of nipple	0.000	0.998	0.002
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
M10.9 Gout, unspecified	0.002	0.998	0.000
N64.1 Fat necrosis of breast	0.000	0.998	0.002
E10.8 With unspecified complications	0.000	0.998	0.002
E10.1 With ketoacidosis	0.000	0.998	0.002
G45.1 Carotid artery syndrome (hemispheric)	0.002	0.998	0.000
H54 Blindness and low vision	0.002	0.998	0.000
E10.0 With coma	0.000	0.998	0.002
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.002	0.998	0.000
M62.86 Other specified disorders of muscle (Lower leg)	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.002	0.998	0.000
H52.4 Presbyopia	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
E10.7 With multiple complications	0.000	0.998	0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.998	0.002
Y44.2 Anticoagulants	0.000	0.998	0.002
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
S62.3 Fracture of other metacarpal bone	0.002	0.998	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.998	0.002
H52.6 Other disorders of refraction	0.002	0.998	0.000
H52.5 Disorders of accommodation	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
H52.7 Disorder of refraction, unspecified	0.002	0.998	0.000
H54.9 Unspecified visual impairment (binocular)	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
B35.3 Tinea pedis	0.002	0.998	0.000
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
E10.9 Without complications	0.000	0.998	0.002
H04.2 Epiphora	0.000	0.998	0.002
H54.4 Blindness, one eye	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
N90.4 Leukoplakia of vulva	0.002	0.998	0.000
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
M71.29 Synovial cyst of popliteal space [Baker]-Site unspec	0.000	0.998	0.002
M71.28 Synovial cyst of popliteal space [Baker]-Other	0.000	0.998	0.002
M71.27 Synovial cyst of popliteal space [Baker]-Ankle/Foot	0.000	0.998	0.002
M71.25 Synovial cyst of popliteal space [Baker]-Pelvic/Thigh	0.000	0.998	0.002
M71.24 Synovial cyst of popliteal space [Baker]-Hand	0.000	0.998	0.002
M71.23 Synovial cyst of popliteal space [Baker]-Forearm	0.000	0.998	0.002
M71.22 Synovial cyst of popliteal space [Baker]-Upper arm	0.000	0.998	0.002
M71.21 Synovial cyst of popliteal space [Baker]-Shldr region	0.000	0.998	0.002
M71.20 Synovial cyst of popliteal space [Baker]-Mult sites	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.000	0.998	0.002
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
E28.2 Polycystic ovarian syndrome	0.002	0.998	0.000
G83.4 Cauda equina syndrome	0.000	0.998	0.002
J06.9 Acute upper respiratory infection, unspecified	0.002	0.998	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.998	0.002
N04 Nephrotic syndrome	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
E10.2 With renal complications	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.002	0.998	0.000
D35.0 Adrenal gland	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
M62.82 Other specified disorders of muscle (Upper arm)	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.002	0.998	0.000
L23.5 Allergic contact dermatitis due to other chemical products	0.000	0.998	0.002
E10.6 With other specified complications	0.000	0.998	0.002
F40.2 Specific (isolated) phobias	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.998	0.002
I72.0 Aneurysm of carotid artery	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
Z59.8 Other problems relating to housing and economic circumstances	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.002
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
S01.4 Open wound of cheek and temporomandibular area	0.000	0.998	0.002
T86.8 Failure and rejection of other transplanted organs and tissues	0.002	0.998	0.000
O63.1 Prolonged second stage (of labour)	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
U50 Level of care administered to neonates	0.000	0.998	0.002
U07 Emergency use of U07	0.000	0.998	0.002
U06 Emergency use of U06	0.000	0.998	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.998	0.002
U52 First in a series of a regular day/night admissions	0.000	0.998	0.002
I72.9 Aneurysm of unspecified site	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
M13.98 Arthritis, unspecified (Other)	0.000	0.998	0.002
G45 Transient cerebral ischaemic attacks and related syndromes	0.002	0.998	0.000
D35.9 Endocrine gland, unspecified	0.002	0.998	0.000
D35.8 Pluriglandular involvement	0.002	0.998	0.000
D35.7 Other specified endocrine glands	0.002	0.998	0.000
D35.6 Aortic body and other paraganglia	0.002	0.998	0.000
D35.5 Carotid body	0.002	0.998	0.000
D35.4 Pineal gland	0.002	0.998	0.000
D35.3 Craniopharyngeal duct	0.002	0.998	0.000
M62.8 Other specified disorders of muscle	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
E10.4 With neurological complications	0.000	0.998	0.002
N90.0 Mild vulvar dysplasia	0.002	0.998	0.000
M79.80 Other specified soft tissue disorders (Multiple sites)	0.000	0.998	0.002
H53.4 Visual field defects	0.002	0.998	0.000
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
S62.31 Fracture of other metacarpal bone (open)	0.002	0.998	0.000
K51.5 Mucosal proctocolitis	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
T51.0 Ethanol	0.000	0.998	0.002
I72 Other aneurysm	0.000	0.998	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.001
T41.4 Anaesthetic, unspecified	0.000	0.998	0.001
T41.3 Local anaesthetics	0.000	0.998	0.001
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.001
T41.1 Intravenous anaesthetics	0.000	0.998	0.001
T41.0 Inhaled anaesthetics	0.000	0.998	0.001
G83.1 Monoplegia of lower limb	0.000	0.998	0.002
N20.9 Urinary calculus, unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
X67.9 Unspecified place	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
U51 Admission status on psychiatric patients	0.000	0.998	0.002
D41.4 Bladder	0.002	0.998	0.000
I72.1 Aneurysm of artery of upper extremity	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.001
T36.8 Other systemic antibiotics	0.000	0.998	0.001
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.001
T36.6 Rifamycins	0.000	0.998	0.001
T36.5 Aminoglycosides	0.000	0.998	0.001
T36.2 Chloramphenicol group	0.000	0.998	0.001
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.001
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
S01.0 Open wound of scalp	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.001
T48.5 Anti-common-cold drugs	0.000	0.998	0.001
T48.4 Expectorants	0.000	0.998	0.001
T48.3 Antitussives	0.000	0.998	0.001
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.001
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.001
T48.0 Oxytocic drugs	0.000	0.998	0.001
I72.8 Aneurysm of other specified arteries	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.001
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.001
T47.7 Emetics	0.000	0.998	0.001
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.001
T47.5 Digestants	0.000	0.998	0.001
T47.3 Saline and osmotic laxatives	0.000	0.998	0.001
T47.2 Stimulant laxatives	0.000	0.998	0.001
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.001
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
G45.3 Amaurosis fugax	0.002	0.998	0.000
H54.5 Low vision, one eye	0.001	0.998	0.000
I72.3 Aneurysm of iliac artery	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.001
U06.9 Emergency use of U06.9	0.000	0.998	0.001
U06.8 Emergency use of U06.8	0.000	0.998	0.001
U06.7 Emergency use of U06.7	0.000	0.998	0.001
U06.6 Emergency use of U06.6	0.000	0.998	0.001
U06.5 Emergency use of U06.5	0.000	0.998	0.001
U06.4 Emergency use of U06.4	0.000	0.998	0.001
U06.3 Emergency use of U06.3	0.000	0.998	0.001
U06.2 Emergency use of U06.2	0.000	0.998	0.001
U06.1 Emergency use of U06.1	0.000	0.998	0.001
U06.0 Emergency use of U06.0	0.000	0.998	0.001
U07.9 Emergency use of U07.9	0.000	0.998	0.001
U07.8 Emergency use of U07.8	0.000	0.998	0.001
U07.7 Emergency use of U07.7	0.000	0.998	0.001
U07.6 Emergency use of U07.6	0.000	0.998	0.001
U07.5 Emergency use of U07.5	0.000	0.998	0.001
U07.4 Emergency use of U07.4	0.000	0.998	0.001
U07.3 Emergency use of U07.3	0.000	0.998	0.001
U07.2 Emergency use of U07.2	0.000	0.998	0.001
U07.1 Emergency use of U07.1	0.000	0.998	0.001
U07.0 Emergency use of U07.0	0.000	0.998	0.001
U50.9 Inquest Adjourned Death	0.000	0.998	0.001
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.001
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.001
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.001
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.001
G83 Other paralytic syndromes	0.000	0.998	0.002
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.002	0.998	0.000
T36.4 Tetracyclines	0.000	0.998	0.001
T49.9 Topical agent, unspecified	0.000	0.998	0.001
T49.8 Other topical agents	0.000	0.998	0.001
T49.7 Dental drugs, topically applied	0.000	0.998	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.001
T49.2 Local astringents and local detergents	0.000	0.998	0.001
T49.1 Antipruritics	0.000	0.998	0.001
S72.20 Subtrochanteric fracture (closed)	0.000	0.998	0.002
G45.2 Multiple and bilateral precerebral artery syndromes	0.001	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.001
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.001
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.001
M62.87 Other specified disorders of muscle (Ankle and foot)	0.000	0.998	0.001
M62.84 Other specified disorders of muscle (Hand)	0.000	0.998	0.001
F42.0 Predominantly obsessional thoughts or ruminations	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.001
T50.8 Diagnostic agents	0.000	0.998	0.001
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.002	0.998	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.000	0.998	0.001
M21.0 Valgus deformity, not elsewhere classified	0.002	0.998	0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified	0.000	0.998	0.001
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.001
T47.4 Other laxatives	0.000	0.998	0.001
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.001
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.002	0.998	0.000
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.001
E28 Ovarian dysfunction	0.002	0.998	0.000
H52.1 Myopia	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.001
T50.5 Appetite depressants	0.000	0.998	0.001
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.001
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.001
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.001
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.998	0.001
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.998	0.001
R59.0 Localised enlarged lymph nodes	0.000	0.998	0.002
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.001
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)	0.000	0.998	0.001
N04.2 Diffuse membranous glomerulonephritis	0.001	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.3 Methadone	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.001
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)	0.000	0.998	0.001
R23.4 Changes in skin texture	0.000	0.998	0.001
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.001
T38.7 Androgens and anabolic congeners	0.000	0.998	0.001
T38.5 Other oestrogens and progestogens	0.000	0.998	0.001
T38.4 Oral contraceptives	0.000	0.998	0.001
T38.2 Antithyroid drugs	0.000	0.998	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.001
T40.5 Cocaine	0.000	0.998	0.001
T40.1 Heroin	0.000	0.999	0.001
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.999	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.999	0.001
N00-N08 Glomerular diseases	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations